ASHLEE EICHENLAUB: Open Payments
NPI 1376083857 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 73 payments from 11 companies in 2025. Trend: 2023 $1,787 · 2024 $579 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $220 |
| Ardelyx, Inc. | 16 | $217 |
| PFIZER INC. | 10 | $163 |
| ABBVIE INC. | 11 | $143 |
| Janssen Biotech, Inc. | 6 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
| Gilead Sciences, Inc. | 4 | $65 |
| Madrigal Pharmaceuticals | 3 | $53 |
| EVOKE PHARMA, INC. | 2 | $34 |
| Celltrion USA Inc. | 2 | $31 |
Products named: XIFAXAN, IBSRELA, TREMFYA, XELJANZ, ENTYVIO, CREON, VELSIPITY, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
